1. Estimation of PfRh5-based vaccine efficacy in asymptomatic Plasmodium falciparum patients from high-endemic areas of Tanzania using genetic and antigenicity variation screening.
- Author
-
Jun H, Mazigo E, Lee WJ, Louis JM, Syahada JH, Fitriana F, Heo J, Kim Y, Kwon B, Muh F, Lu F, Ahmed MA, Lee SJ, Na S, Chun W, Park WS, Hong M, Han JH, Kwon TH, Lee SU, Han ET, Todd J, Manjurano A, Kidima W, and Han JH more...
- Subjects
- Humans, Tanzania epidemiology, Female, Male, Adult, Cross-Sectional Studies, Adolescent, Antibodies, Protozoan blood, Antibodies, Protozoan immunology, Vaccine Efficacy, Child, Young Adult, Protozoan Proteins immunology, Protozoan Proteins genetics, Child, Preschool, Middle Aged, Endemic Diseases prevention & control, Genetic Variation, Carrier Proteins, Plasmodium falciparum immunology, Plasmodium falciparum genetics, Malaria, Falciparum immunology, Malaria, Falciparum prevention & control, Malaria, Falciparum epidemiology, Malaria, Falciparum parasitology, Malaria Vaccines immunology, Antigens, Protozoan immunology, Antigens, Protozoan genetics, Antigenic Variation genetics
- Abstract
Background: Plasmodium falciparum is the most lethal malaria parasite. Recent phase 1b vaccine trials using P. falciparum reticulocyte binding protein homolog 5 (PfRh5) demonstrated safety and promising efficacy in preventing merozoite invasion. PfRh5 has emerged as a strong vaccine candidate due to its essential role in merozoite invasion and limited sequence variation. For effective malaria vaccine development, especially in high-transmission settings, strain-transcending activity must be considered. Ongoing monitoring of antigenic variation and natural immune responses is important to estimate vaccine efficacy across geographically diverse populations., Methods: Samples for this study were collected from four villages in each of the Kigoma and Geita regions, known malaria transmission hotspots in Tanzania. This community-based cross-sectional study was conducted from December 2022 to July 2023. Genetic variation and natural selection pressure on pfrh5 were analyzed in 164 asymptomatic P. falciparum isolates. The humoral immune response to PfRh5 was also assessed using a protein microarray with 242 sera samples from asymptomatic patients in the same population. Finally, a correlation analysis was conducted to compare pfrh5 genetic variation with the humoral immune response., Results: The results revealed that pfrh5 was well conserved, but novel non-synonymous mutations were found at D65H, H170N, and I227M. Additionally, natural selection metrics indicated the potential for positive selection and a recent population expansion of PfRh5 in the study area, both of which could influence vaccine effectiveness. Antigenicity screening revealed variable sensitivity, ranging from 3.3% in Bunyambo to 82.8% in Rwantaba, with no significant relationship between antigenicity and parasitemia, haplotypes, or gender. However, age was significantly associated with humoral immune response ( ρ = 0.170, p = 0.008)., Conclusions: These findings underscore the need for future PfRh5-based vaccines to consider for increasing genetic variation and geographical differences in humoral immune responses., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 Jun, Mazigo, Lee, Louis, Syahada, Fitriana, Heo, Kim, Kwon, Muh, Lu, Ahmed, Lee, Na, Chun, Park, Hong, Han, Kwon, Lee, Han, Todd, Manjurano, Kidima and Han.) more...
- Published
- 2024
- Full Text
- View/download PDF